NEW YORK (GenomeWeb) – German non-profit charitable foundation Stefan-Morsch-Stiftung today announced a collaboration with Dutch molecular diagnostics firm GenDx to increase the HLA typing resolution level of new donors in the non-profit's registry.
Stefan-Morsch-Stiftung will implement GenDx's high-resolution HLA typing method into its next-generation sequencing typing workflow as part of the deal. GexDx's approach combines its HLA typing kits with its NGSengine analysis software.
The partners will together optimize and validate the strategy for the handling of large sample numbers in a timely and cost-efficient fashion, Stefan-Morsch-Stiftung said.
The foundation helps leukemia, thalassemia, and tumor patients and maintains a registry of about 380,000 donors.
"With GenDx we have a strong and reliable partner on our side," Stefan-Morsch-Stiftung Founder Emil Morsch said in a statement. "The implementation of [next-generation sequencing] into the typing routine is an important step in the improvement of patient-donor matching and contributes to a reduction of time to transplant."